The third edition of “Respira con il Cuore”' reflects on the complexity of today for young people and the hopes of tomorrow Music has the power to inspire change, shape the collective culture of an entire generations and enhance the sense of well-being. It is also known to have positive outcomes for…
Designing a carbon minimal inhaler is a complex challenge: Maria Paola Chiesi talks about one of the most ambitious projects of the Group to reduce its carbon footprint Frequently, when talking about the environment, we use the metaphor of “planet’s health”, but we seldom think about how the…
The collaboration among governments and the pharmaceutical industry has the power to deliver outcomes to patients at first, but also to society and economy. Therefore, pharma companies should be considered as a catalyst towards a sustainable and resilient healthcare system, following…
The development of biological products has been continuously and steadily increasing in the last decade: in the global market, according to the data of the Biologics Global Market Report 2021, in the last 30 years the sector has grown at an annual rate of more than 12%. Moreover, the volume of…
At Chiesi we are committed to saving the life of the premature babies and to improving the quality of their life and the air they breathe. For this reason, this year to celebrate the World Prematurity Day (November 17), we launched several initiatives to engage our people all around the world. To…
Chiesi Vendor Day 2021, the event dedicated to the Group's suppliers at an international level, was held on 17th November. Chiesi's suppliers represent a true value network, which is essential for the Company and for its approach to sustainability: in order to ensure that its sustainable business…
Chiesi’s commitment to creating a shared value for patients, society, and the environment is at the center of “Helping the World to Breathe” an inspiring docuseries promoted by the American Thoracic Society (ATS), global leader in in respiratory health. The aim of the series is to draw awareness to…
Chiesi is once again one of the best European companies in terms of Diversity and Inclusion: for the third year running, the Group received the 2022 Diversity Leaders Award, as one of the top 50 European companies (36° position) out of a sample of 850 companies listed. The Group ranked 2° among the…
Chiesi Global Rare Diseases was launched with a central mission in mind: “Revolutionize the lives of people living with rare diseases.” The patient voice shapes our team. That is why it is so important to join together and celebrate the strength of the rare disease community. We are proud to share…
You are leaving the Chiesi Corp site to access another Chiesi site. Regulatory constraints and medical practices, as well as the information published on the site you are about to visit, may change from one country to another and may not comply with current Italian legislation on the subject.
You are about to leave our website and access an external site. By continuing, you agree to leave our site.
